Fu et al. reported that the potential role of LYNX1 in modulating lung cancer cell growth is supported by the increase in cholinergic signaling reported in lung cancers in which levels of Ach and nicotinic receptors are increased [24, 36]. This evidence concerns the gene FGFR3 and lung carcinoma.